Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SEPT9 Gene Methylation as a Noninvasive Marker for Hepatocellular Carcinoma

29 Oct 2020

Abstract excerpt

Background. Early detection appears to be the most effective approach to improve the overall survival of patients with hepatocellular carcinoma (HCC). We evaluated the potential performance of plasma SEPT9 methylation (mSEPT9) as a noninvasive biomarker for the diagnosis of patients with HCC. Methods. A total of 373 subjects were included, and the group consisted of 104 HCC patients, 95 with an at-risk disease,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Liver Disease Diagnosis and Treatment
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33178361
DOI: 10.1155/2020/6289063

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SEPT9 Gene Methylation as a Noninvasive Marker for Hepatocellular CarcinomaPMID 33178361Read ↗

Plasma mSEPT9: A Novel Circulating Cell-free DNA-Based Epigenetic Biomarker to Diagnose Hepatocellular CarcinomaSemantic proximity Read ↗

Diagnostic Value of Plasma Septin9 Methylation Combined with Multi-indicator Detection in the Progression of Primary Liver CancerSemantic proximity Read ↗

Advance in plasma SEPT9 gene methylation assay for colorectal cancer early detectionSemantic proximity Read ↗

Early detection and prognosis evaluation for hepatocellular carcinoma by circulating tumour DNA methylation: A multicentre cohort studySemantic proximity Read ↗

Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal CancerSemantic proximity Read ↗

Circulating DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancerSemantic proximity Read ↗

HepaClear, a blood-based panel combining novel methylated CpG sites and protein markers, for the detection of early-stage hepatocellular carcinomaSemantic proximity Read ↗

Plasma SGIP1 methylation in diagnosis and prognosis prediction in hepatocellular carcinomaSemantic proximity Read ↗

Circulating-tumour DNA methylation of HAND1 gene: a promising biomarker in early detection of colorectal cancerSemantic proximity Read ↗

Hepatocellular Carcinoma Detection by Plasma Methylated DNA: Discovery, Phase I Pilot, and Phase II Clinical ValidationSemantic proximity Read ↗

Sensitive Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation AssaySemantic proximity Read ↗

From Discovery to the Clinic: The Novel DNA Methylation Biomarker <i> <sup>m</sup> </i> SEPT9 For The Detection of Colorectal Cancer in BloodSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.